Sign In
Buy PRNB
$100.05
+0 (+0%)
At Close: May 27, 2022
Sanofi completes Principia Biopharma Inc. acquisition
09:30am, Monday, 28'th Sep 2020
Sanofi completes Principia Biopharma Inc. acquisition
Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Principia Biopharma Inc.
01:00am, Tuesday, 22'nd Sep 2020
Sanofi announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), applicable to Sanofi’s proposed acquisition of Principi
Sanofi to commence tender offer for acquisition of Principia Biopharma Inc.
01:00am, Friday, 28'th Aug 2020
NEW YORK, NY / ACCESSWIRE / August 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:Analog Devices, Inc.
MERGER ALERT - SKYS, PRNB, and PFNX: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies
08:20pm, Wednesday, 19'th Aug 2020
NEW YORK, NY / ACCESSWIRE / August 19, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:Levi & Korsinsky, LLP announces that investigations have commenced on behalf of sharehold
SHAREHOLDER ALERT: Monteverde & Associates Is Investigating the Merger
03:55pm, Wednesday, 19'th Aug 2020
NEW YORK, NY / ACCESSWIRE / August 19, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New
Johnson & Johnson Is Buying Momenta Pharmaceuticals. Both Stocks Are Gaining.
03:22pm, Wednesday, 19'th Aug 2020
(JNJ) said Wednesday morning it had agreed to buy the biotech firm (MNTA) in an all-cash $6.5 billion deal, acquiring rights to Momenta’s experimental drug nipocalimab, which has potential uses in
Johnson & Johnson Buys Biotech Momenta Pharmaceuticals for $6.5 Billion
12:46pm, Wednesday, 19'th Aug 2020
(JNJ) said Wednesday morning it had agreed to buy the biotech firm (MNTA) in an all-cash $6.5 billion deal, acquiring rights to Momenta’s experimental drug nipocalimab, which has potential uses in
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
12:00am, Wednesday, 19'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 18)
Avenue Therapeutics Inc (NASDAQ: ATXI)
Checkmate Pharmaceuticals Inc (NASDAQ: CMPI)
DarioHealth Corp (NASDAQ:...
NEW YORK, NY / ACCESSWIRE / August 18, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:GCI Liberty, Inc.
Sanofi Is Buying Principia Biopharma for $3.7 Billion. Why Wall Street Is Cheering the Deal.
02:42pm, Tuesday, 18'th Aug 2020
The French drugmaker Sanofi’s $3.7 billion acquisition of the biotech Principia Biopharma is good news for Sanofi stock, Wall Street has determined.
Principia (PRNB) Looks Good: Stock Adds 9.4% in Session
12:45pm, Tuesday, 18'th Aug 2020
Principia (PRNB) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
(PRNB) Alert: Johnson Fistel Investigates Proposed Sale of Principia Biopharma; Are Shareholders Getting a Fair Price?
10:19am, Tuesday, 18'th Aug 2020
SAN DIEGO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Principia Biopharma Inc. ("Principia " or t
Principia Bought By Sanofi, And Other News: The Good, Bad And Ugly Of Biopharma
03:38am, Tuesday, 18'th Aug 2020
Sanofi agrees to acquire Principia Bio for $3.68 billion. Bill Gates-backed Novavax begins COVID-19 mid-stage trial.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
Catalent Inc (NYSE: CTLT)
CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday...
